Methylprednisolone Alternatives Compared
| Methylprednisolone | Meloxicam | Prednisone |
|
|---|
| Methylprednisolone | Meloxicam | Prednisone |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Methylprednisolone effectively controls inflammation and an overactive immune system but may not be suitable for everybody. Long-term use is limited by potentially severe side effects such as... View more |
Prescription only
Meloxicam is effective for the short-term relief of pain and inflammation associated with arthritis; however, like other NSAIDs, it has the potential to adversely affect the stomach or heart and... View more |
Prescription only
Prednisone effectively controls inflammation and an overactive immune system but may not be suitable for everybody. Long-term use is limited by potentially severe side effects such as adrenal... View more |
Related suggestions Rheumatoid Arthritis
Inflammatory Conditions
|
|||||||||||||||||||||||
| More about Methylprednisolone | More about Meloxicam | More about Prednisone | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Methylprednisolone has an average rating of 7.0 out of 10 from a total of 447 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 26% reported a negative effect. |
Meloxicam has an average rating of 6.2 out of 10 from a total of 585 ratings on Drugs.com. 54% of reviewers reported a positive effect, while 34% reported a negative effect. |
Prednisone has an average rating of 7.5 out of 10 from a total of 819 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 18% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
See also: methylprednisolone side effects in more detail. |
See also: meloxicam side effects in more detail. |
See also: prednisone side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all methylprednisolone prices |
View all meloxicam prices |
View all prednisone prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Depo-Medrol, Medrol, Medrol Dosepak, MethylPREDNISolone Dose Pack, Solu-Medrol | Anjeso, Mobic | Rayos | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
3.5 hours |
20 hours |
4 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category C
Risk cannot be ruled out
Excluding First Trimester
Category D
Positive evidence of risk
First Trimester See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Prior To 30 Weeks Gestation
Category D
Positive evidence of risk
Starting At 30 Weeks Gestation See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
Excluding First Trimester
Category D
Positive evidence of risk
First Trimester See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 553 drugs are known to interact with methylprednisolone:
|
A total of 372 drugs are known to interact with meloxicam:
|
A total of 553 drugs are known to interact with prednisone:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
April 23, 2018 |
N/A |
July 26, 2012 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.